From the Cochrane Library: Interventions for Pityriasis Rosea (Preprint)
Preprint
- 2 January 2023
- preprint
- Published by JMIR Publications Inc. in JMIR Preprints
Abstract
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).Keywords
All Related Versions
- Published version: JMIR Dermatology, 6 (1), e45388.
This publication has 5 references indexed in Scilit:
- Pityriasis rosea as a cutaneous manifestation of COVID‐19 infectionJournal of the European Academy of Dermatology and Venereology, 2020
- Interventions for pityriasis roseaCochrane Database of Systematic Reviews, 2019
- Ibrutinib-associated pityriasis rosea–like rashJAAD Case Reports, 2018
- Vaccine‐induced pityriasis rosea and pityriasis rosea‐like eruptions: a review of the literatureJournal of the European Academy of Dermatology and Venereology, 2014
- Pityriasis rosea: An update with a critical appraisal of its possible herpesviral etiologyJournal of the American Academy of Dermatology, 2009